Psorizide Ultra

Psorizide Ultra

Psorizide Ultra Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Medroxyprogesterone Acetate Injectable Suspension, USP is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that occurs during pregnancy and/or lactation, in the risk/benefit assessment for women who use Medroxyprogesterone Acetate Injectable Suspension, USP long-term [see Warnings and Precautions (5.1)].

 

History

There is currently no drug history available for this drug.

Other Information

Medroxyprogesterone Acetate Injectable Suspension, USP contains medroxyprogesterone acetate, a derivative of progesterone, as its active ingredient. Medroxyprogesterone acetate is active by the parenteral and oral routes of administration. It is a white to off-white; odorless crystalline powder that is stable in air and that melts between 200°C and 210°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.

The chemical name for Medroxyprogesterone Acetate is pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6α-).

The structural formula is as follows:

MM1

Medroxyprogesterone Acetate Injectable Suspension, USP for intramuscular (IM) injection is available in vials and prefilled syringes, each containing 1 mL of medroxyprogesterone acetate sterile aqueous suspension 150 mg/mL.

For Medroxyprogesterone Acetate Injectable Suspension, USP vials, each mL contains:

Medroxyprogesterone acetate150 mg
Polyethylene glycol 335028.9 mg
Polysorbate 802.41 mg
Sodium chloride8.68 mg
Methylparaben1.37 mg
Propylparaben0.150 mg
Water for injectionquantity sufficient

When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both.

For Medroxyprogesterone Acetate Injectable Suspension, USP prefilled syringes, each mL contains:

Medroxyprogesterone acetate150 mg
Polyethylene glycol 335028.5 mg
Polysorbate 802.37 mg
Sodium chloride8.56 mg
Methylparaben1.35 mg
Propylparaben0.147 mg
Water for injectionquantity sufficient

When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both.

 

Psorizide Ultra Manufacturers


  • Plymouth Pharmaceuticals Inc Dba Loma Lux Laboratories
    Psorizide Ultra (Potassium Bromide, Nickel Sulfate, And Zinc Bromide) Tablet [Plymouth Pharmaceuticals Inc Dba Loma Lux Laboratories]

Login To Your Free Account